Talcum Powder Litigation Report
Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
SEARCH THE ARCHIVES
Issue #30, May 2019
A South Carolina jury has found in favor of Johnson & Johnson on claims that a woman’s cancer was caused by her use of the company's talcum powder.
A New York jury has awarded $25 million in compensatory damages at the conclusion of an asbestos cosmetic talcum powder trial against Johnson & Johnson and answered affirmatively that the plaintiffs are entitled to punitive damages, HarrisMartin Publishing is reporting.
A Delaware court has ruled that Johnson & Johnson has not established that provisional transfer is warranted of “essentially every talc case pending against it,” rejecting the defendant’s efforts to move all state court talcum powder claims to the court overseeing Imerys Talc America’s bankruptcy petition.
Issue #29, April 2019
Talcum powder ovarian cancer claims pending in Georgia state court that were scheduled for a July trial are among the thousands that were removed to federal court as part of an effort by Johnson & Johnson to have the cases linked to Imerys Talc America’s bankruptcy proceedings.
Talcum Powder Ovarian Cancer Case That Didn’t Name Imerys Talc as Defendant Among Thousands Recently Removed
A talcum powder ovarian case that did not name Imerys Talc America Inc. as a defendant is among the thousands recently removed by Johnson & Johnson defendants in their efforts to have the bankruptcy court overseeing Imerys’ Chapter 11 petition assert jurisdiction over pending state court claims.
A New Jersey federal judge has denied a request by a Johnson & Johnson shareholder to issue an injunction forcing Johnson & Johnson’s shareholders to resolve their securities disputes via arbitration rather than class action litigation.
J&J Defendants Ask Bankruptcy Court to Assert Jurisdiction over Mesothelioma, Ovarian Cancer Talcum Powder Claims
Johnson & Johnson and Johnson & Johnson Consumer Inc. have filed a motion to fix venue for claims related to Imerys Talc America Inc.’s bankruptcy, arguing that underlying mesothelioma and ovarian cancer talcum powder claims affect the debtors’ estates.
Johnson & Johnson defendants have filed a brief defending a trial court order tossing a $417 million verdict in an ovarian cancer talcum powder case, maintaining that there is only a weak statistical association between talc and ovarian cancer.
The appeal relating to a trial court order that threw out a $417 million verdict in an ovarian cancer talcum powder verdict has been fully briefed, according the appellate court’s online docket.
J&J Defendants File Brief in Venue Dispute in Multi-Plaintiff Talc Case, Say Plaintiffs Have ‘Zero Connection’ to City of St. Louis
The Johnson & Johnson defendants involved in a multi-plaintiff talcum powder ovarian cancer case that was scheduled to be tried in January before the Missouri Supreme Court stopped it have filed a brief in support of their position that the claims should be severed and transferred, arguing that that joinder of plaintiffs who have “zero connection to the City of St. Louis with those of a single plaintiff whose claims are properly venued there is contrary to Missouri law.”